Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 68.0 | 42 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 74.5 | 56 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 83.0 | 53 | |
RA2159 | EO1428 | 1.0 | uM | 3 | SCGF-b | 60.5 | 32 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 61.0 | 55 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 73.0 | 79 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 60.0 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 61.5 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 86.0 | 57 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 71.0 | 70 | |
N2586 | EO1428 | 1.0 | uM | 3 | SCGF-b | 95.0 | 61 | ||||
0 | SCGF-b | 43.0 | 43 | ||||||||
RA2159 | 3 | SCGF-b | 86.0 | 55 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | SCGF-b | 76.5 | 60 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | SCGF-b | 80.5 | 54 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | SCGF-b | 75.5 | 32 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 83.5 | 56 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | SCGF-b | 72.0 | 47 | ||||
RA2159 | 3 | SCGF-b | 85.0 | 51 | |||||||
N2586 | 3 | SCGF-b | 102.0 | 51 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | SCGF-b | 64.5 | 44 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | SCGF-b | 59.5 | 50 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | SCGF-b | 78.5 | 56 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 63.0 | 61 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | SCGF-b | 88.0 | 31 |